Stephen and Sandy Sheller were honorary attendees at Mural Arts Philadelphia’s 2021 Wall Ball, The Art of Wellbeing. Held virtually June 10, 2021 at 6:00
Johnson & Johnson is out of options after the U.S. Supreme Court declined to hear the pharmaceutical company’s appeal of a $70 million Risperdal verdict.
When executive compensation is tied solely to short term profits, and not balanced against company payouts for wrongdoing, there’s an increased incentive for executive fraud.
Provision of medicinesBENICAR lawsuits over serious gastrointestinal injury have been consolidated in New Jersey.
Contact the national defective drug attorneys at Sheller, PC by calling 800-883-2299 or filling out the inquiry form at the bottom of this page if you have been hospitalized or under ongoing medical treatment for serious stomach or related digestive injuries while taking BENICAR. You may have a case against the manufacturer of the drug for a lawsuit.
Sheller, P.C. is investigating the serious digestive side effects and injuries linked to the blood pressure drug BENICAR including:
Other side effects may include:
Per the WSJ, Thomas A. Marciniak, a senior regulator at the FDA, went against his supervisors to advocate stronger warnings about the drugs known as angiotensin receptor blockers, or ARBs, but those warnings went unheeded.
In 2010, a study published in Lancet Oncology, that looked at five studies involving 68,402 patients and found that people taking ARBs had an 11% greater risk of new cancer overall and a 25% greater risk of new lung cancer, compared with patients who didn’t get the drugs.
Contact the BENICAR attorneys at Sheller, P.C. at 800-883-2299 or fill out the inquiry form on this page if you or someone you know has experienced these side effects. The firm offers a no-cost, no obligation consultation.
Links
FDA Adds GI Warning to Benicar Label, MedPage Today, July 3, 2013
Dispute Flares Inside FDA Over Safety of Popular Blood Pressure Drugs, The Wall Street Journal, May 30, 2013
Sheller, P.C.
1515 Market Street, Suite 1100
Philadelphia, PA 19102
Phone: 215-790-7300
info@sheller.com
